Pcn230 - Are Nice and the SMC Diverging in Their Assessment of Oncology Drugs?

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.312
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Are We Prep-Ared for Differences Between Nice and SMC Decision Making?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Comparison of Recent Hta Appraisals of Orphan Drugs by Nice, SMC and Has in 2015-2017

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

Pcn302 - Is the New Nice Appraisal Process for Oncology Indications Too Positive in Its Assessment of Cancer Drugs in England?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pcn305 - Nice and the Cancer Drugs Fund – Can Observational Evidence Inform Funding Decisions in Oncology?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Why Are European Countries Diverging in Their Unemployment Experience?

Journal of Economic Perspectives
EconomicsEconometrics
2004English

Aligned and Flexible? A Comparative Review of SMC and Nice Decision-Making

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Pcn288 - Has the New Nice Appraisal Process for Oncology Drugs Delivered Faster Patient Access to Innovative Treatments?

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Php232 - A Comparison of Cost-Effectiveness Assessments Between Nice and SMC Technology Appraisals

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Pmd171 - Health Technology Assessment of Companion Diagnostics Alongside Therapeutc Agents in Oncology: Experience of the Nice Technology Appraisal Programme

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy